Amnioinfusión como método de prevención del síndrome de aspiración meconial.
ABSTRACT: Introduction: According to the World Health Organization, the prevalence of meconium amniotic fluid in developing countries is from 5 to 25%. Meconium amniotic fluid aspiration syndrome is a respiratory disorder caused by meconium aspiration into the bronchial tree of the newborn, it can o...
Збережено в:
| Автор: | |
|---|---|
| Інші автори: | |
| Формат: | bachelorThesis |
| Мова: | spa |
| Опубліковано: |
2023
|
| Предмети: | |
| Онлайн доступ: | http://dspace.unach.edu.ec/handle/51000/10258 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Додати тег | Резюме: | ABSTRACT: Introduction: According to the World Health Organization, the prevalence of meconium amniotic fluid in developing countries is from 5 to 25%. Meconium amniotic fluid aspiration syndrome is a respiratory disorder caused by meconium aspiration into the bronchial tree of the newborn, it can occur before, during or after delivery, approximately 12% of deliveries have meconium amniotic fluid and can be the cause of respiratory distress. Objective: The objective of this research was to establish the benefits of amnioinfusion as a method of prevention of Meconium Aspiration Syndrome. Methodology: It is a descriptive, documentary type of research, supported by the analytical method since the data will be obtained from an exhaustive bibliographical review taking into account guidelines and eligibility criteria. Results and discussion: Highly significant studies, meta-analyses and randomized trials have been described, which address the benefits provided by amnioinfusion, especially in the prevention of Meconium Aspiration Syndrome, with which it was possible to demonstrate several studies that affirm certain benefits mentioned in the literature, while on the other hand only two studies were able to demonstrate that there is no decrease in both fetal and maternal mortality and a multicenter study that demonstrated that it does not reduce the risk of meconium aspiration syndrome. However, currently research continues to support the preventive benefits against Meconium Aspiration Syndrome. Conclusions: Amnioinfusion prevents intrauterine meconium emission, dilutes meconium, corrects Oligohydramnios, decreases umbilical cord compression, lowers the rate of cesarean delivery and respiratory distress. |
|---|